Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evidence for a two-stage disability progression in multiple sclerosis.
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord.
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
T-cell trafficking in the central nervous system.
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Color-Code Agreement Among Stratus, Cirrus, and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis With and Without Prior Optic Neuritis.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
Cerebrospinal fluid analysis.
Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
Longitudinal study of alexithymia and multiple sclerosis.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Vitamin D in MS: A vitamin for 4 seasons.
[Vitamin D tweets light to genes in multiple sclerosis].
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Acquired perforating dermatosis associated with natalizumab.
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Pages
« first
‹ previous
…
242
243
244
245
246
247
248
249
250
…
next ›
last »